Related Experiment Video

Updated: Jun 11, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection

Carl Guévin1, David Manna, Claudia Bélanger

  • 1Institut National de la Recherche Scientifique-Institut Armand-Frappier (INRS-IAF), Laval, Québec, Canada.

Virology
|June 29, 2010
PubMed

Insights

Autophagy protein ATG5 interacts with Hepatitis C virus (HCV) NS5B, aiding early viral infection. Silencing ATG5 blocks HCV replication, highlighting autophagy

Area of Science:

  • Virology
  • Cellular Biology
  • Molecular Biology

Background:

  • Autophagy, a cellular process initiated by ATG5, forms double-membrane vesicles (DMVs).
  • DMVs are known to host viral replication complexes for positive-strand RNA viruses.
  • Autophagy proteins have recently been implicated as proviral factors in Hepatitis C virus (HCV) infection.

Purpose of the Study:

  • To investigate the interaction between autophagy protein ATG5 and HCV proteins.
  • To determine the role of ATG5 in the early stages of HCV infection.
  • To assess the impact of ATG5 inhibition on HCV replication.

Main Methods:

  • Co-immunoprecipitation (co-IP) and metabolic labeling to confirm ATG5/NS5B interaction.
  • Immunofluorescence staining to analyze the colocalization of ATG5 with HCV proteins (NS5B and NS4B).
  • ATG5 silencing to inhibit autophagy and evaluate its effect on HCV replication.

Main Results:

  • ATG5 was identified as an interacting protein for the HCV NS5B protein.
  • ATG5 colocalizes with NS4B and NS5B in infected cells during early infection (2 days postinfection).
  • This colocalization diminishes by 5 days postinfection, suggesting a role in infection initiation.
  • ATG5 silencing significantly blocks HCV replication, confirming its proviral role.

Conclusions:

  • HCV utilizes the autophagy protein ATG5 as a proviral factor during the onset of infection.
  • The interaction and colocalization of ATG5 with viral proteins facilitate early viral replication.
  • Targeting ATG5 or autophagy pathways could be a potential therapeutic strategy against HCV.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...